Literature DB >> 22922920

Kawasaki disease: always straight to the heart?

Henning Clausen1, Claire Howarth, Alessandro Giardini.   

Abstract

Kawasaki disease is an important differential diagnosis when evaluating prolonged fever in childhood. Although the aetiology of this vasculitic disease process remains obscure, prompt recognition and treatment significantly reduces vascular complications such as coronary artery aneurysms. Patients presenting with atypical or incomplete diagnostic features remain a challenge. Here the authors describe the atypical features of Kawasaki disease that led to profound acute hearing loss in a 6-year-old boy with complex congenital heart disease. Coronary changes were not seen on early follow-up, but the patient required bilateral hearing aids. Considering Kawasaki disease early, even in the possibly confusing context of complex congenital heart disease and atypical symptomatology, is crucial to avoid long-term sequelae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922920      PMCID: PMC4544902          DOI: 10.1136/bcr-2012-006505

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Late intravenous immunoglobulin treatment in patients with Kawasaki disease.

Authors:  Hiromi Muta; Masahiro Ishii; Mayumi Yashiro; Ritei Uehara; Yosikazu Nakamura
Journal:  Pediatrics       Date:  2012-01-16       Impact factor: 7.124

2.  Sensorineural hearing loss associated with Kawasaki disease.

Authors:  R P Sundel; J W Newburger; T McGill; S S Cleveland; W W Miller; B Berry; A M Klein; J C Burns
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

Review 3.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

4.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

5.  Sensorineural hearing loss: an underdiagnosed complication of Kawasaki disease.

Authors:  Cristina M R Magalhães; Natália R Magalhães Alves; Karina Maria A Oliveira; Isabella M C Silva; Lenora Gandolfi; Riccardo Pratesi
Journal:  J Clin Rheumatol       Date:  2010-10       Impact factor: 3.517

6.  Kawasaki disease and sensorineural hearing loss: an (un)expected complication.

Authors:  Ana Novo; Susana Pinto; Ana Catarina Prior; Sílvia Alvares; Teresa Soares; Margarida Guedes
Journal:  Eur J Pediatr       Date:  2012-01-07       Impact factor: 3.183

7.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

8.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

9.  Audiologic profiles of children with Kawasaki disease.

Authors:  R P Sundel; S S Cleveland; A S Beiser; J W Newburger; T McGill; A L Baker; G Koren; R E Novak; J P Harris; J C Burns
Journal:  Am J Otol       Date:  1992-11

Review 10.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children.

Authors:  R M Oates-Whitehead; J H Baumer; L Haines; S Love; I K Maconochie; A Gupta; K Roman; J S Dua; I Flynn
Journal:  Cochrane Database Syst Rev       Date:  2003
  10 in total
  3 in total

1.  Sensorineural hearing loss--another under-recognized oto-laryngeal complication of Kawasaki disease.

Authors:  Shailendra Kapoor
Journal:  Eur J Pediatr       Date:  2015-06-07       Impact factor: 3.183

2.  Sensorineural hearing loss in patients with Kawasaki disease.

Authors:  Sun Young Park; Young Hyun Kim; Yeo Hyang Kim; Myung Chul Hyun; Young Hwan Lee
Journal:  Korean J Pediatr       Date:  2015-11-22

3.  Impact of Early Treatment With High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children.

Authors:  Alireza Karimi Yazdi; Parvin Akbariasbagh; Yahya Aghighi; Seyyed Reza Raeeskarami; Khadije Toomaj; Sahar Heidari; Shahnaz Alamdari; Leyla Sahebi
Journal:  J Family Reprod Health       Date:  2021-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.